Result
€6.0m ▲ 696%
The result rose in 2025 from €752,865 to €6.0m.
Signifeye
Lifetime
17 annual accounts with figures on one time axispeak €2.3m (2025)
€2.3m
lowest -€725,122 (2023)
€6.0m▲ 696%
peak €14.2m (2025)
€14.2m▲ 91.8%
€4.5m▼ 50.7%
Board29 names since 2020all names
15 directorsBernard Heintz and 14 others
Owners3 names in the annual accounts
1.17%DR. R. VAN LANDEGHEM
Documentsfilings and deeds
01-07-202630 days before the deadline
2025financial year
Result from €752,865 to €6.0mCapital increase of €790,000 to €7,881,500 27-11Appointment: Ann Haustermans (director) 18-08Equity from €7.4m to €14.2mDebts from €9.2m to €4.5mInvestments €2.3m
Key points
from the 2025 annual accountsLiquidity
1.69 was 0.61 in 2024
Short-term debts fell from €5.0m to €1.7m.
Filings
17 annual accounts since 2007
The last five annual accounts were filed 19 to 54 days before the end of the period.
Group
11 companies controlled
Heads a group.
Board
7 joined · 9 left
Board changed. Latest change 22-09-2026 · 8 in office.
Position in the sector
€6.0m
Higher net result than 95% of companies in wholesale trade. Sector median €110,308 · 6,124 companies.
Checked score
99
Excellent
Financially stronger than 91% of medium-sized companies in wholesale trade (NACE 46)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 746 companies (NACE 46, medium-sized).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.4%▲ +0.1 percentage points vs 04-2025
06-2025: 0.5%▲ +0.1 percentage points vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025highest value
08-2025: 0.2%▼ -0.3 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.1%▼ -0.1 percentage points vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 1.69, cash €230,392
lowers risk
Size: total assets €18.7m
Founded in 2006
Figures for financial year 2025 (filed on 01-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized). It does better than 93% of them on solvency, 77% on liquidity, 99% on profitability and 96% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit verdict
Credit of up to €1,400,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.69 (0.61 in 2024), above the usual 1.5. Short-term debt is 9% and cash 1.2% of total assets. 24.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €14.2m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
30 days early
2024
30 days early
2023
54 days early
2022
31 days early
2021
19 days early
2020
25 days early
2019
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 32 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
CN
Cotton Nicholas
Director, since 02-02-2026
- DR. R. VAN LANDEGHEM 1.17%score 91equity €23,170 (2025) · 2025 annual accounts of DR. R. VAN LANDEGHEM
- Dr Irina Balikova 0.01%score 92equity €22,525 (2025) · 2024 annual accounts of Dr Irina Balikova
Recent changes
4 directors appointed, 2 resignations
Resignations: Movendis BV and Nicolas Coton · Permanent representative: Kathleen Moons · Appointments: Guilia Mazza, Peter Byloos, Lode Vlaminck and Merel Venneman (day-to-day manager) · General meeting of 25-08-2026 · Gazette deed
2 directors appointed, 12 resignations
Change of role: MOVENDIS BV, from director to managing director · Resignations: Fernand De Wilde, Maria Dieltiëns, Ann Haustermans, Bernard Heintz, Frank Kesteloot, Huib Lodewijks and 6 others · Permanent representatives: Jean Assaf, Ivan D'hauwe, Kathleen Moons and Eddy Verbrugge · General meeting of 02-02-2026 · Gazette deed
Amendment of the articles
Capital of €7,881,500, 28,890,000 shares · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0884161037
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Signifeye Antwerp | €18.7m | €2.3m | 75.7% | - |
| GLOBIFER INTL Kontich | €11.1m | €3.3m | 2.6% | 0.8 |
| HEFRA Turnhout | €10.7m | €1.2m | 98.9% | 3 |
| X-RIS Seraing | €10.8m | €4.5m | 39.1% | 32 |
| GYMNA Diepenbeek | €8.9m | €4.3m | 46.3% | 38 |
| ANDOCOR Hoogstraten | €12.3m | €4.2m | 38.2% | 39.5 |
| LDI INTERNATIONAL Antwerp | €6.7m | €3.1m | 48.5% | - |
These companies have the same main activity as Signifeye: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €6.7m and €12m, founded between 1996 and 2012.
Official details
Source: KBO- Status
- Active since 11-10-2006Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
- Establishment unit
- 2.157.208.9322610 Antwerp, since 07-11-2006
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Annual accounts 2025
- ≈ €9.5mestimated
- €18.7m▲ 12.7%
- Filing
- Filed on 01-07-2026, 30 days before the end of the filing period
Insights on Signifeye
Signifeye has existed since 2006. The gross margin grew from €156,611 in 2007 to €2.3m in 2025.
Solvency rose in 2025 from 44.5% to 75.7% because of the retained profit and a capital increase and lower debts.
In February 2026, eleven directors stepped down. In March 2026, the Official Gazette published the appointment of MOVENDIS as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Signifeye
- What is the company number of Signifeye?
- The company number of Signifeye is 0884.161.037. The VAT number is the same number with BE in front: BE 0884.161.037.
- Where is Signifeye based?
- The registered office is at Boomsesteenweg 223, 2610 Antwerp.Company details
- What does Signifeye do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Signifeye?
- Signifeye is a public limited company (NV).
- When was Signifeye founded?
- Signifeye was founded on 11-10-2006.
- Is Signifeye still active?
- Yes, Signifeye is an active enterprise in the KBO register.
- What is the turnover of Signifeye?
- The turnover in financial year 2025 is ≈ €9.5m. This figure is estimated from the gross margin of €2.3m and 98 comparable companies (NACE 46). It probably lies between €5.7m and €16.0m. In financial year 2024 turnover was €2.8m.Financials
- Is Signifeye profitable?
- In financial year 2025, Signifeye made a profit of €6.0m.
- Where can I find the annual accounts of Signifeye?
- Signifeye filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Signifeye due?
- Signifeye must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.Signifeye · 12 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.